Tolerance to organ transplants: Is chimerism bringing it closer than we think?

Current Opinion in Organ Transplantation

Volumn 12, Issue 4, 2007, Pages 329-334

  Ildstad, Suzanne T ^a,c,d   Breidenbach, Warren C ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b CHRISTINE M KLEINERT INSTITUTE FOR HAND AND MICROSURGERY   (United States)

^c Institute for Cellular Therapeutics   (United States)

^d JEWISH HOSPITAL   (United States)

Author keywords

Facilitating cells; Hematopoietic chimerism; Tolerance

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; CYCLOSPORIN; FLUDARABINE; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ALLOIMMUNITY; BONE MARROW TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CHIMERA; DENDRITIC CELL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; NONMYELOABLATIVE CONDITIONING; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; WHOLE BODY RADIATION;

EID: 34447521477     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32826fbcde     Document Type: Review

References (42)

1. Merrill JP, Murray JE, Harrison JH, Guild WR. Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc 1956; 160:277-282.
2. Barr ML, Kobashigawa JA. Improving long-term outcomes of heart transplantation: cardiac allograft vasculopathy, malignancy, and treatment options. Transplantation 2006; 1:1-12.
3. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931-940.
4. Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353:770-781.
5. Kaufman DB, Leventhal JR, Gallon LG, Parker MA. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreaskidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results. Am J Transplant 2006; 6:331-339. Steroid-sparing immunosuppressive protocols allow reduced immunosuppression.
6. Shirwan H. Allograft tolerance: is it a journey toward achieving the impossible? Current Opin Org Transplant 2006; 11:351-352.
7. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102:400-401.
8. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance to foreign cells. Nature 1953; 172:603-607.
9. McCurry KR, Colvin BL, Zahorchak AF, Thomson AW. Regulatory dendritic cell therapy in organ transplantation. Transpl Int 2006; 19:525-538. Dendritic cell-based therapies offer promise as a cell-based therapeutic.
10. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210.
11. Thomas ED, Lochte HL, Cannon JH, et al. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 1959; 381:1709-1716.
12. Newell KA, Larsen CP. Toward transplantation tolerance: a large step on a long road. Am J Transplant 2006; 6:1989-1990.
13. Storb R, Yu C, Wagner JL, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997; 89:3048-3054.
14. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169:493-502.
15. Sharabi Y, Aksentijevich I, Sundt TM, et al. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172:195-202.
16. Exner BG, Colson YL, Li H, Ildstad ST. In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning. Surgery 1997; 122:221-227.
17. Gammie JS, Li S, Colson YL, et al. A partial conditioning strategy for achieving mixed chimerism in the rat: Tacrolimus and antilymphocyte serum substantially reduce the minimum radiation dose for engraftment. Exp Hematol 1998; 26:927-935.
18. Xu H, Chilton PM, Huang Y, et al. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol 2004; 172:1463-1471.
19. Kean LS, Gangappa S, Pearson TC, Larsen CP. Transplant tolerance in nonhuman primates: progress, current challenges and unmet needs. Am J Transplant 2006; 6:884-893.
20. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307:168-170.
21. Kuhr CS, Allen MD, Junghanss C, et al. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 2002; 73:1487-1492.
22. Niemeyer GP, Welch JA, Tillson M, et al. Renal allograft tolerance in DLAidentical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil. Transplant Proc 2005; 37:4579-4586.
23. Yunusov MY, Kuhr C, Georges GE, et al. Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results. Transplant Proc 2002; 34:3366-3367.
24. Boskovic S, Kawai T, Smith RN, et al. Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation 2006; 82:819-825.
25. Fudaba Y, Spitzer TR, Shaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006; 6:2121-2133. This report summarizes the outcomes in six patients with multiple myeloma who underwent nonmyeloablative BMT plus renal transplant.
26. Pang M, Li S, Salgar S, et al. Donor bone marrow infusion reduces the infiltration of recipient-derived CD4 and dendritic cells in lung allograft [abstract]. J Surg Res 2006; 130:176-177.
27. Pham SM, Rao AS, Zeevi A, et al. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 2000; 119:673-681.
28. Mcsweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97:3390-3400.
29. UNSCEAR. Sources, effects and risks of ionizing radiation, Report to the General Assembly. New York: United Nations; 1988. 30 ICRP 26 [report]. Oxford: ICRP; 2006.
30. Mettler FA Jr, Kelsey CA, Ricks RC. Medical management of radiation accidents. Boca Raton: CRC Press; 1985.
31. Baron F, Maris MB, Sandmaier BM, et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol 2005; 23:1993-2003.
32. Maraninchi D, Gluckman E, Blaise D, et al. Impact of T-cell depletion on outcome of allogeneic bone marrow transplantation for standard risk leukemias. Lancet 1987; 2:175-178.
33. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75:555-562.
34. reg.
35. Rezvani K, Mielke S, Ahmadzadeh M, et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006; 108:1291-1297.
36. Porter SB, Liu B, Rogosheske J, et al. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs. Transplantation 2006; 82:23-29.
37. reg.
38. - graft facilitating cells enhance HSC clonogenicity and prevent apoptosis of HSC: a requirement for direct FC:HSC crosstalk [abstract]. In: Proceedings of the American Transplant Congress; 5-9 May 2007; San Francisco. Arlington/Mt.Laurel: AmericanSociety of TransplantSurgeons/American Society of Transplantation; 2007.
39. Fugier-Vivier I, Rezzoug F, Huang Y, et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med 2005; 201:373-383.
40. Kaufman CL, Colson YL, Wren SM, et al. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84:2436-2446.
41. Grimes HL, Schanie CL, Huang Y, et al. Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. Exp Hematol 2004; 32:946-954.
42. Colson YL, Wright RD. Facilitating cells: FCp33/TCRβ heterodimer expression and the absence of GVHD effector activity [abstract]. J Am Coll Surg 2002; 195:S1-S115.